Drug Submission Services

Drug submissions fail most often because information is missing, inconsistent, or poorly organized. We structure your filings so regulators can follow the science and quality story without confusion. 

Starting at the planning stage, we map the right pathway, outline module structure, and identify evidence gaps before you invest in formatting. For new products, we prepare submission packages and compile dossiers in eCTD‑ready formats, weaving clinical, nonclinical, and CMC content into a coherent narrative. Our document control checks ensure that data, tables, and labelling are aligned from section to section.

Before any application goes in, we perform a detailed quality review against Health Canada and FDA expectations, addressing deficiencies that commonly trigger clarification requests. After approval, we continue to support lifecycle management, variations, and periodic filings so your product remains compliant as requirements evolve. The outcome is fewer regulatory surprises, more predictable review timelines, and a smoother path from development bench to commercial supply.